Prevalence and characteristics of chronic obstructive pulmonary disease in Havana (2017-2018)
Keywords:
chronic obstructive lung disease, prevalence, severity of illness index, risk.Abstract
Introduction: In Cuba, chronic obstructive pulmonary disease is the sixth leading cause of death. There is insufficient knowledge concerning its scope.
Objective: To determine the prevalence and characteristics of the disease in Havana (2017-2018).
Methods: A multicenter, cross-sectional study coordinated by Iniciative Burden of Lung Disease. It included 349 non-hospitalized people aged 40 and over from four family doctor´s offices (random selection). A questionnaire with sociodemographic variables on previous medical diagnosis and smoking was applied. A spirometric study was conducted before and after salbutamol administration to determine airflow limitations, and the disease was classified as mild, moderate, severe, and very severe.
Results: Overall prevalence was 20.9% (95 % CI: 16.6-25.2); with males accounting for 25.3%; and females for 17.7%. It increased with age. Mild forms of the disease affected 60% of the population; they were more common in females (67%) than in males (severe forms, 22%). Previous spirometry was performed in 15% of respondents. Fourteen people (19.1%) had previously been diagnosed with pulmonary emphysema, chronic bronchitis, or chronic obstructive pulmonary disease. Smoking prevalence was 36%, with a higher percentage in the severe forms of the disease. One-third (31.7%) were exposed to second-hand tobacco smoke at home or at work, with a daily average exposure of 5 hours.
Conclusions: Chronic obstructive pulmonary disease is a major health problem in Havana due to its high prevalence and underdiagnosis. An increase in prevalence is predicted given the demographic dynamics in the country and the high level of tobacco consumption among the population. Therefore, more comprehensive management of this preventable disease is required.
Downloads
References
Global Initiative for chronic obstructive lung disease (GOLD).Global Strategy for Diagnosis, Management and Prevention or Chronic Obstructive pulmonary disease. Report 2018.
Montes de Oca M, López M, Schiavi E, Rey M, Jardim J. Guía Latinoamericana de EPOC – 2014, Basada en Evidencia. Asociación Latinoamericana de Tórax (ALAT), 2015. Disponible en: https://alatorax.org/es/descargar/.../197-ltcqhg-epoc2015-23abr2015-electronico.pdf
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and Regional mortality from 235 causes of death for 20 age groups in 1990 y 2010: a systematic analysis for the Global Burden for Disease Study 2010. Lancet [Internet] 2012 [cited Sept 20 2018];380(9859):2095-128. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61728-0/fulltext
Lopez-Campos J l, Tan W, Soriano J B. Global burden of COPD. Respirology 2016; 21: 14-23.
Woodruff PG, Barr RG, Blecker E, Christenson SA, Couper D, Curtis JL, et al. Clinical significance of symptoms in smokers with normal pulmonary function. N Engl J Med [Internet]2016[cited Agust 12 2018];374(19):1811-21. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1505971
Regan EA, Lynch DA, Curran-Everett D, Autin JHM, Grenier PA, Kauczor HU, et al. Clinical and radiologic disease in smokers with normal sprirometry. JAMA Intern Med [Internet]2015[cited March 12 2017];175(9):1539-49. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2323415
American Thoracic Society Foundation. The Globan Burden of Lung Disease. 2014. American Thoracic Society Foundation. The Globan Burden of Lung Disease; 2014
Murray CJL, López AD. Alternaive Projections of mortality and disability by cause 1990-2010:GlobaL Burden of Disease Stydy. Lancet [Internet]1997[cited March 17 2017];349(9064):1498-504. Available from: http://info-centre.jenage.de/assets/pdfs/library/murray_lopez_et_al_LANCET_1997.pdf
Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AMB, e al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD [Internet]2005[cited March 23 2017];2:277-83. Available from: https://pdfs.semanticscholar.org/cd71/eba7cdd187cccf90b3374a08cd1bd483cb25.pdf
Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health [Internet]2015[cited May 2017];5(2).Available from:https://www.semanticscholar.org/paper/Global-and-regional-estimates-of-COPD-prevalence%3A-Adeloye-Chua/543d7a3392bbd6c090649943072362bb17a388fa
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional and national age-sex specific all-cause and cause specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet [Internet]2015 Jan 10 [cited July 26 2018];385(9963):117-71. Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2814%2961682-2
Menezes AMB, Perez–Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet.[Internet] 2005 Nov 26 [cited Oct 24 2017];366(9500):1875–81. Available from:https://www.sciencedirect.com/science/article/pii/S0140673605676325
Caballero A, Torres–Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. [Internet]2008 Feb [cited January 21 2016];133(2):343–9.Available from: https://pdfs.semanticscholar.org/5fe8/4e182dd660ff099cb32167acdd690e771310.pdf?_ga=2.122225102.416563308.1560359702-439432715.1543246437
Ciapponi A et al. The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis. COPD 2014; 11: 339-50. https://www.researchgate.net/publication/257645569_
Venero S, Varona P, Molina E, Suarez R. Tendencia de la mortalidad por Enfermedad Pulmonar de Vías Respiratorias Inferiores. Cuba, 1987-2011. Rev.Cub.Hig.Epid, 2018; 56. Dsponible en: https://www.researchgate.net/publication/289996824
Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2017. [Internet].La Habana: MINSAP; 2018 [citado February 23 2019]. Dsiponible en: http://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Espa%C3%B1ol-2017-ed-2018.pdf
Guevara Lezica R. Estudio epidemiológico de la bronquitis crónica en un sector de Alamar. Pesquisa activa. Policlínico Alamar.[Tesis]. La Habana: Universidad de La Habana; 1985.
Díaz Novas J, Fernández Sacasas. Principales problemas de salud que afectan al Médico de Familia.Rev.Cub.deMed.Gen.Int.1990;6(2):247-255.
García Castañeda H, Valdés Díaz S, García Silvera E, Fernández García S, Fernández Fernández M. Problemas de salud pulmonar em adultos mayores. Hogar de Santovenia. GEROINFO.[Internet]2009[citado March 16 2018];4(3):1-9. Disponible en: http://www.sld.cu/galerias/pdf/sitios/gericuba/salud_pulmonar_en_ancianos.pdf
Asociación médica mundial. Declaración de Helsinky. Principios éticos para la investigación en seres humanos 2008.
Buist AS, Vollmer WM, Sullivan S, et al. The Burden of Lung . Disease Initiative (BOLD): rationale and design. COPD 2005; 2: 277–83. https://pdfs.semanticscholar.org/cd71/eba7cdd187cccf90b3374a08cd1bd483cb25.pdf
Celli B, Decramer M , Wedzicha J, Wilson K , Agust A, Criner G, Pulmonary Disease. Am J Respir Crit CAre Med 2015; 191:4-27. www.atsjournals.org
Montes de Oca M, Lopez MA, Varela ME, Contreras A, Casas E, Schiavi A, Silva A. Clasificación de los pacientes con enfermedad pulmonar obstructiva cónica según los sistemas de estadificación de la Asociación l latinoamericana de Tórax (ALAT) y la iniciativa global para la enfermedad pulmonar obstructiva crónica(GOLD), Arch Bronconeumol 2017;53(3):98-106. Disponible en www.archbroncomeumol.org
Programa SPSS (Statistical Package for Social Sciences) versión 20 para Windows y EPIDAT (Programa para Análisis Epidemiológico de Datos Tabulados) versión 3.0.
Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, Demeo DL, the COPD Gene Investigators. Early-onset COPD is associated with female gender, maternal factors, and African American Race in the COPD Gene study. Am J Respir Crit Care Med 2011;184:414 e 20.
Taussig L, Wright A, Holberg C, Halonen M, Martínez F. Tucson Children's Respiratory Study: 1980 to present. Allergy and clinical immunology, 2003;1114:661-75.
Lee A, Mazzoni A, Glujovsky D, Cesaroni S, Sobrino E. The Epidemiology and Burden of COPD in Latin America and the Caribbean: Systematic Review and Meta-Analysis. Journal of chronic pulmonary disease, 11:339–350, 2014
Ancochea J, Badiola C, Duran-Taulería E, Garcia Rio F, Miravitlles M, Mu˜ nozL, et al. The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40 to 80 year olds: Protocol Summary. Arch Bronconeumol. 2009;45:41–7
Miravitllesa M, Soler-Cataluña Juan, Calle M, Molina J, Almagro P, Quintano J. Guía española de la EPOC (Ges EPOC). Actualización 2014. Arch Bronconeumol. 2014;50(Supl 1):1-16. Disponible en www. archbronconeumol.org
U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections, January 2014.
Jordan RE, Cheng KK, Miller MR, Adab P. Passive smoking and chronic obstructive pulmonary disease: cross–sectional analysis of data from the Health Survey for England. BMJ Open. 2011;1(2):e000153.
Bonet Gorbea, M., Varona Pérez, P. III Encuesta de factores de riesgo y actividades preventivas de enfermedades no transmisibles. Cuba 2010-2011. La Habana: Editorial Ciencias Médicas; Disponible en: http://www.bvs.sld.cu/libros/encuesta_nacional_riesgo/encuesta_nacional_completo.pdf
Published
How to Cite
Issue
Section
License
La Revista Cubana de Higiene y Epidemiologia protege los derechos de autor, y opera con una Licencia Creative Commons 4.0.(Licencia Creative Commons Atribución-No Comercial 4.0 Internacional (CC BY-NC 4.0).Al publicar en ella los autores permiten copiar y redistribuir el material en cualquier medio o formato; remezclar, transformar y crear a partir del material. Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia http://creativecommons.org/licenses/by-nc/4.0/ e indicar si se han realizado cambios. No puede utilizar el material para una finalidad comercial. No hay restricciones adicionales.
Los autores autorizan la publicación de sus escritos conservando los derechos de autoría, y cediendo y transfiriendo a la revista todos los derechos protegidos por las leyes de propiedad intelectual que rigen en Cuba, que implican la edición para difundir la obra.
Los autores podrán establecer acuerdos adicionales para la distribución no exclusiva de la versión de la obra publicada en la revista (por ejemplo, situarla en un repositorio institucional o publicarla en un libro), con el reconocimiento de haber sido publicada primero en esta revista.
